BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 26232916)

  • 1. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ).
    Assaf AT; Zrnc TA; Riecke B; Wikner J; Zustin J; Friedrich RE; Heiland M; Smeets R; Gröbe A
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e157-64. PubMed ID: 24011463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
    Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
    J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
    Dore F; Filippi L; Biasotto M; Chiandussi S; Cavalli F; Di Lenarda R
    J Nucl Med; 2009 Jan; 50(1):30-5. PubMed ID: 19091894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Yoshiga D; Sasaguri M; Matsuo K; Kokuryou S; Habu M; Oda M; Kodama M; Tsurushima H; Sakaguchi O; Sakurai T; Tanaka J; Morimoto Y; Yoshioka I; Tominaga K
    Osteoporos Int; 2015 Jul; 26(7):1997-2006. PubMed ID: 26037792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardised uptake value.
    Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
    Clin Radiol; 2020 Jan; 75(1):46-50. PubMed ID: 31699430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate characterization of
    Zhang L; He Q; Zhou T; Zhang B; Li W; Peng H; Zhong X; Ma L; Zhang R
    BMC Med Imaging; 2019 May; 19(1):44. PubMed ID: 31146746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab-related osteonecrosis of the jaws: successful management with a conservative surgical approach.
    de Souza Póvoa RC; Marlierè DA; da Silveira HM; Pires FR
    Spec Care Dentist; 2016 Jul; 36(4):231-6. PubMed ID: 26859582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ).
    Hoefert S; Yuan A; Munz A; Grimm M; Elayouti A; Reinert S
    J Craniomaxillofac Surg; 2017 Apr; 45(4):570-578. PubMed ID: 28238559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw.
    Zhao Y; Wang L; Liu Y; Akiyama K; Chen C; Atsuta I; Zhou T; Duan X; Jin Y; Shi S
    Calcif Tissue Int; 2012 Dec; 91(6):400-8. PubMed ID: 23064899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of
    Parghane RV; Singh B; Sharma A; Singh H; Singh P; Bhattacharya A
    J Nucl Med Technol; 2017 Dec; 45(4):280-284. PubMed ID: 28798229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-fluorescence of the bone and its use for delineation of bone necrosis.
    Ristow O; Pautke C
    Int J Oral Maxillofac Surg; 2014 Nov; 43(11):1391-3. PubMed ID: 25128260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
    Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
    Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (99m)Tc-MDP SPECT/CT as the one-stop imaging modality for the diagnosis of early setting of Kienbock's disease.
    Arora S; Singh Dhull V; Karunanithi S; Kumar Parida G; Sharma A; Shamim SA
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):185-7. PubMed ID: 25824583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease.
    Bedogni A; Fedele S; Bedogni G; Scoletta M; Favia G; Colella G; Agrillo A; Bettini G; Di Fede O; Oteri G; Fusco V; Gabriele M; Ottolenghi L; Valsecchi S; Porter S; Petruzzi M; Arduino P; D'Amato S; Ungari C; Fung Polly PL; Saia G; Campisi G
    Br J Oral Maxillofac Surg; 2014 Sep; 52(7):603-8. PubMed ID: 24856927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws.
    Pichardo SE; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):272-8. PubMed ID: 27234854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.